|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.67 HKD | -1.44% |
|
+2.10% | +17.29% |
| 04/02 | Berun Chemical Agrees to 1.90 Billion Yuan Settlement Over Share Capital Dispute | MT |
| 13/01 | China Coal Energy's Output, Sales Slip in December | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.46 | 6.05 | 6.34 | 5.97 | 5.5 | |||||
Return on Total Capital | 4.44 | 7.93 | 8.53 | 8.1 | 7.59 | |||||
Return On Equity % | 7.4 | 14.21 | 16.47 | 14.8 | 13.31 | |||||
Return on Common Equity | 5.96 | 12.31 | 14.88 | 14.21 | 13.05 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 25.84 | 18.05 | 25.1 | 25 | 24.64 | |||||
SG&A Margin | 11.63 | 2.29 | 2.8 | 3.38 | 3.51 | |||||
EBITDA Margin % | 17.76 | 17.2 | 19.87 | 22.7 | 21.72 | |||||
EBITA Margin % | 11.34 | 12.97 | 15.62 | 17.8 | 17.28 | |||||
EBIT Margin % | 10.88 | 12.66 | 15.24 | 17.06 | 16.44 | |||||
Income From Continuing Operations Margin % | 6.33 | 8.22 | 11.51 | 13.34 | 13.18 | |||||
Net Income Margin % | 4.19 | 5.75 | 8.27 | 10.12 | 10.2 | |||||
Net Avail. For Common Margin % | 4.19 | 5.75 | 8.27 | 10.12 | 10.2 | |||||
Normalized Net Income Margin | 3.25 | 5.33 | 6.66 | 7.46 | 7.36 | |||||
Levered Free Cash Flow Margin | 7.11 | 12.77 | 11.6 | 10.85 | 9.39 | |||||
Unlevered Free Cash Flow Margin | 9.18 | 13.87 | 12.69 | 11.84 | 10.23 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.51 | 0.76 | 0.67 | 0.56 | 0.54 | |||||
Fixed Assets Turnover | 1.07 | 1.76 | 1.73 | 1.52 | 1.41 | |||||
Receivables Turnover (Average Receivables) | 10.22 | 16.81 | 13.73 | 12.93 | 13.97 | |||||
Inventory Turnover (Average Inventory) | 13.74 | 24.84 | 18.7 | 16 | 17.32 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.9 | 1.2 | 1.18 | 1.22 | 1.11 | |||||
Quick Ratio | 0.74 | 1.04 | 1.05 | 1.09 | 0.98 | |||||
Operating Cash Flow to Current Liabilities | 0.33 | 0.55 | 0.42 | 0.44 | 0.33 | |||||
Days Sales Outstanding (Average Receivables) | 35.82 | 21.71 | 26.59 | 28.23 | 26.2 | |||||
Days Outstanding Inventory (Average Inventory) | 26.64 | 14.69 | 19.52 | 22.81 | 21.13 | |||||
Average Days Payable Outstanding | 76.27 | 43.81 | 50.47 | 56.16 | 58.8 | |||||
Cash Conversion Cycle (Average Days) | -13.81 | -7.4 | -4.36 | -5.12 | -11.47 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 77.6 | 68.65 | 52.4 | 40.22 | 33.49 | |||||
Total Debt / Total Capital | 43.69 | 40.7 | 34.38 | 28.69 | 25.09 | |||||
LT Debt/Equity | 59.05 | 52.99 | 32.52 | 28.17 | 24.22 | |||||
Long-Term Debt / Total Capital | 33.25 | 31.42 | 21.34 | 20.09 | 18.15 | |||||
Total Liabilities / Total Assets | 56.03 | 55.74 | 51.47 | 47.68 | 46.29 | |||||
EBIT / Interest Expense | 3.29 | 7.15 | 8.71 | 10.74 | 12.21 | |||||
EBITDA / Interest Expense | 5.38 | 9.73 | 11.39 | 14.33 | 16.17 | |||||
(EBITDA - Capex) / Interest Expense | 3.17 | 7.19 | 8.86 | 8.6 | 9.09 | |||||
Total Debt / EBITDA | 3.83 | 2.45 | 1.97 | 1.67 | 1.56 | |||||
Net Debt / EBITDA | 2.4 | 0.62 | -0.1 | -0.41 | -0.48 | |||||
Total Debt / (EBITDA - Capex) | 6.49 | 3.32 | 2.53 | 2.79 | 2.78 | |||||
Net Debt / (EBITDA - Capex) | 4.06 | 0.84 | -0.13 | -0.68 | -0.86 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.99 | 63.96 | -8.03 | -12.52 | -1.85 | |||||
Gross Profit, 1 Yr. Growth % | 0.95 | 70.34 | 30.99 | -12.87 | -3.41 | |||||
EBITDA, 1 Yr. Growth % | 3.22 | 56.91 | 8.72 | -14.09 | -6.4 | |||||
EBITA, 1 Yr. Growth % | 3.7 | 83.99 | 12.5 | -17.46 | -5.09 | |||||
EBIT, 1 Yr. Growth % | 4.29 | 88.72 | 12.89 | -18.97 | -5.5 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 3.82 | 112.82 | 30.22 | 1.38 | -3.09 | |||||
Net Income, 1 Yr. Growth % | 4.9 | 124.85 | 32.76 | 6.98 | -1.08 | |||||
Normalized Net Income, 1 Yr. Growth % | -4.67 | 161.57 | 16.66 | -23.85 | -3.22 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 6.03 | 124.45 | 32.76 | 6.74 | -0.86 | |||||
Accounts Receivable, 1 Yr. Growth % | -19.26 | 23.8 | 7.89 | -20.85 | 5.44 | |||||
Inventory, 1 Yr. Growth % | -13.71 | 16.06 | 12.34 | -6.58 | -11.35 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2.85 | -3.84 | -2.12 | 1.31 | 10.15 | |||||
Total Assets, 1 Yr. Growth % | 3.35 | 13.71 | 5.42 | 2.69 | 2.46 | |||||
Tangible Book Value, 1 Yr. Growth % | 1.41 | 21.46 | 31.42 | 7.06 | 9.98 | |||||
Common Equity, 1 Yr. Growth % | 3.76 | 11.56 | 14.36 | 10.13 | 5.41 | |||||
Cash From Operations, 1 Yr. Growth % | 2.96 | 112.56 | -9.28 | -1.53 | -20.54 | |||||
Capital Expenditures, 1 Yr. Growth % | -5.83 | 1.15 | -6.44 | 80.14 | 2.82 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 33.17 | 187.8 | -13.06 | -30.12 | -15.2 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 22.33 | 143.48 | -12.48 | -29.4 | -15.34 | |||||
Dividend Per Share, 1 Yr. Growth % | 5.51 | 124.63 | 37.21 | 7.02 | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 16.34 | 33.68 | 25.09 | -10.3 | -7.34 | |||||
Gross Profit, 2 Yr. CAGR % | 10.79 | 7.54 | 50.36 | 6.83 | -8.19 | |||||
EBITDA, 2 Yr. CAGR % | 14.91 | 28.05 | 31.51 | 4.24 | -10.19 | |||||
EBITA, 2 Yr. CAGR % | 15.53 | 39.45 | 45.41 | 5.9 | -11.31 | |||||
EBIT, 2 Yr. CAGR % | 15.83 | 41.08 | 47.2 | 5.15 | -12.44 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 20.52 | 48.67 | 68.59 | 14.94 | -0.88 | |||||
Net Income, 2 Yr. CAGR % | 32.71 | 53.61 | 75.72 | 19.24 | 2.87 | |||||
Normalized Net Income, 2 Yr. CAGR % | 20.88 | 59.95 | 76.66 | 6.94 | -14.13 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 33.46 | 54.3 | 75.72 | 19.1 | 2.87 | |||||
Accounts Receivable, 2 Yr. CAGR % | -12.21 | -0.1 | 16.53 | -7.59 | -8.65 | |||||
Inventory, 2 Yr. CAGR % | -7.72 | 0.13 | 15.09 | 2.45 | -9 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 0.8 | -0.43 | -2.82 | -0.42 | 5.64 | |||||
Total Assets, 2 Yr. CAGR % | 3.22 | 8.65 | 9.64 | 4.06 | 2.57 | |||||
Tangible Book Value, 2 Yr. CAGR % | 1.77 | 11.25 | 26.91 | 18.69 | 8.51 | |||||
Common Equity, 2 Yr. CAGR % | 4.64 | 8.2 | 13.23 | 12.27 | 7.74 | |||||
Cash From Operations, 2 Yr. CAGR % | 5.26 | 47.94 | 38.85 | -5.48 | -11.55 | |||||
Capital Expenditures, 2 Yr. CAGR % | 4.52 | -2.4 | -2.71 | 29.82 | 36.1 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 18.22 | 98.03 | 57.95 | -15.64 | -22.97 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 14.33 | 74.13 | 45.79 | -15.47 | -22.65 | |||||
Dividend Per Share, 2 Yr. CAGR % | 31.07 | 53.95 | 75.56 | 21.18 | 7.69 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 20.03 | 30.44 | 19.48 | 11.03 | -7.57 | |||||
Gross Profit, 3 Yr. CAGR % | 11.56 | 12.04 | 15.35 | 25.35 | 3.36 | |||||
EBITDA, 3 Yr. CAGR % | 13.96 | 28.01 | 21.81 | 20.01 | 0.67 | |||||
EBITA, 3 Yr. CAGR % | 16.63 | 35.77 | 30.74 | 28.22 | 2.24 | |||||
EBIT, 3 Yr. CAGR % | 17.21 | 36.8 | 31.71 | 28.5 | 1.51 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 28.64 | 45.69 | 43.45 | 42.34 | 8.59 | |||||
Net Income, 3 Yr. CAGR % | 37.09 | 58.23 | 47.98 | 48.98 | 12.04 | |||||
Normalized Net Income, 3 Yr. CAGR % | 19.48 | 57.69 | 45.06 | 45.17 | 3.46 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 37.09 | 58.74 | 48.51 | 48.87 | 12.04 | |||||
Accounts Receivable, 3 Yr. CAGR % | -8.22 | -1.6 | 3.06 | 2.43 | -3.44 | |||||
Inventory, 3 Yr. CAGR % | -2.74 | -0.35 | 4.6 | 7.36 | -2.38 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 0.97 | -0.69 | -0.88 | -1.46 | 2.98 | |||||
Total Assets, 3 Yr. CAGR % | 3.79 | 6.77 | 7.66 | 7.28 | 3.53 | |||||
Tangible Book Value, 3 Yr. CAGR % | 1.09 | 8.13 | 17.96 | 19.97 | 15.71 | |||||
Common Equity, 3 Yr. CAGR % | 4.14 | 7.3 | 10.39 | 12.21 | 9.93 | |||||
Cash From Operations, 3 Yr. CAGR % | 8.84 | 33.05 | 25.68 | 23.82 | -10.8 | |||||
Capital Expenditures, 3 Yr. CAGR % | 6.32 | 3.39 | -3.76 | 19.46 | 20.12 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 27.42 | 60.25 | 50.37 | 26.87 | -15.46 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 21.22 | 47.97 | 38.33 | 20.17 | -15.39 | |||||
Dividend Per Share, 3 Yr. CAGR % | 34.56 | 56.85 | 48.15 | 48.86 | 16.75 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 18.92 | 30.67 | 22.03 | 13.13 | 7.93 | |||||
Gross Profit, 5 Yr. CAGR % | 14.69 | 15.52 | 16.12 | 10.21 | 5.28 | |||||
EBITDA, 5 Yr. CAGR % | 27.14 | 26.68 | 20.98 | 18.23 | 11.14 | |||||
EBITA, 5 Yr. CAGR % | 64.52 | 36.38 | 27.87 | 23.45 | 16.25 | |||||
EBIT, 5 Yr. CAGR % | 80.13 | 37.77 | 28.68 | 23.55 | 16.19 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 34.02 | 45.31 | 43.35 | 33.18 | 23.75 | |||||
Net Income, 5 Yr. CAGR % | 18.56 | 45.63 | 51.42 | 42.26 | 27.98 | |||||
Normalized Net Income, 5 Yr. CAGR % | 16.29 | 52.99 | 40.43 | 35.61 | 23.71 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 18.56 | 45.58 | 51.42 | 42.52 | 28.25 | |||||
Accounts Receivable, 5 Yr. CAGR % | -1.59 | 0.92 | 0.94 | -3.73 | -1.79 | |||||
Inventory, 5 Yr. CAGR % | 0.65 | 2.08 | 4.06 | 1.08 | -1.07 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 0.92 | 0.23 | -0.51 | -0.52 | 1.68 | |||||
Total Assets, 5 Yr. CAGR % | 1.85 | 5.87 | 6.19 | 5.73 | 5.6 | |||||
Tangible Book Value, 5 Yr. CAGR % | 2.79 | 6.63 | 10.83 | 12.44 | 14.11 | |||||
Common Equity, 5 Yr. CAGR % | 3.85 | 5.77 | 7.93 | 9.37 | 9.34 | |||||
Cash From Operations, 5 Yr. CAGR % | 25.45 | 31.86 | 19.98 | 16.03 | 9.21 | |||||
Capital Expenditures, 5 Yr. CAGR % | -2.07 | 2.95 | 2.61 | 13.25 | 10.55 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 3.45 | 127.81 | 39.49 | 23.9 | 18.76 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 19.28 | 70.51 | 30.97 | 18.22 | 12.87 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | 50.49 | 49.66 | 41.47 | 30.41 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















